Biotech · Public company · Ocala, FL, US
AIM ImmunoTech Inc.
Ticker AIM · SEC CIK 0000946644
Track this companyFree. Adds AIM ImmunoTech Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials103 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- RintatolimodPhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- RintatolimodPhase 2 · Post COVID-19 ConditionClinicalTrials.gov · fetched Nov 12, 2026
- Poly I: Poly C12U (Rintatolimod)Chronic Fatigue SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPCPHASE2 · SUSPENDED · started Aug 1, 2027ClinicalTrials.gov NCT05494697 · fetched Nov 12, 2026
- Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian CancerPHASE2 · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07634094 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID ConditionsPHASE2 · COMPLETED · started Jun 30, 2023ClinicalTrials.gov NCT05592418 · fetched Nov 12, 2026
- Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer PatientsPHASE1_PHASE2 · TERMINATED · started Nov 17, 2020ClinicalTrials.gov NCT04379518 · fetched Nov 12, 2026
- Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before SurgeryPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 29, 2019ClinicalTrials.gov NCT03899987 · fetched Nov 12, 2026
- Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 28, 2019ClinicalTrials.gov NCT03734692 · fetched Nov 12, 2026
- Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast CancerEARLY_PHASE1 · COMPLETED · started Jan 9, 2019ClinicalTrials.gov NCT03599453 · fetched Nov 12, 2026
- Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC VaccinesPHASE1_PHASE2 · WITHDRAWN · started Sep 4, 2015ClinicalTrials.gov NCT02432378 · fetched Nov 12, 2026
- Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal CancerPHASE1_PHASE2 · TERMINATED · started Oct 1, 2012ClinicalTrials.gov NCT01545141 · fetched Nov 12, 2026
- Ampligen in Chronic Fatigue SyndromeTEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT00215813 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 16, 2026 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed Jun 18, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 15, 2026 · fetched Nov 12, 2026